Delivery Order SPE2DR25D1103-SPE2DR26FE822
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,336.40 by the Defense Logistics Agency on October 24, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is not set-aside and represents a competitive award to support federal medical procurement needs. The contract utilizes a non-competitive delivery order structure, with a completion date of October 27, 2025, and will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,260.00 by the Defense Logistics Agency on January 12, 2026, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was awarded without a set-aside designation through competitive procurement. This award represents a task order under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) valued at $8,597.36 for Trulicity 1.5 mg/0.5 ml pens (0.5 ml vials). The award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,424.13 delivery order by the Defense Logistics Agency on January 6, 2026, for Trulicity 0.75 mg/0.5 mL pen (0.5 mL) with a completion date of January 7, 2026. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The award is issued as a child contract under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE822Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for the supply of Trulicity 4.5 mg/0.5 mL pens in 0.5 mL dosages. This firm fixed-price delivery order, valued at $1,898.88, is scheduled for completion by January 16, 2026, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive IDC with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the overarching IDC with DLA valued at up to $999,999,999.00 through December 2031. Trulicity is a diabetes medication commonly prescribed within military and veterans' healthcare systems, and this delivery represents routine pharmaceutical procurement to support ongoing federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/14/26 |